Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong · Delayed Price · Currency is HKD 6.83
-0.16 (-2.29%)
At close: May 7, 2026
HKG:2566 Market Cap
HKG:2566 has a market cap or net worth of 1.66 billion as of May 7, 2026. Its market cap has increased by 14.24% in one year.
Market Cap
1.66B
Enterprise Value
1.04B
Revenue
1.45B
Ranking
n/a
PE Ratio
10.93
Stock Price
6.83
Market Cap Chart
Since November 28, 2024, HKG:2566's market cap has decreased from 1.88B to 1.66B, a decrease of -11.75%. That is a compound annual growth rate of -8.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 1.69B | -9.00% |
| Dec 31, 2025 | 1.86B | 14.55% |
| Dec 31, 2024 | 1.62B | -13.73% |
| Nov 28, 2024 | 1.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 2.30B |
| Frontage Holdings | 1.99B |
| SinoMab BioScience | 1.98B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.91B |
| Mabpharm | 1.86B |
| Beijing Biostar Pharmaceuticals | 1.71B |
| Cutia Therapeutics | 1.66B |
| Zhaoke Ophthalmology | 1.62B |